630 related articles for article (PubMed ID: 28258616)
1. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.
Kanthabalan A; Peters M; Van Vulpen M; McCartan N; Hindley RG; Emara A; Moore CM; Arya M; Emberton M; Ahmed HU
BJU Int; 2017 Aug; 120(2):246-256. PubMed ID: 28258616
[TBL] [Abstract][Full Text] [Related]
2. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
[TBL] [Abstract][Full Text] [Related]
3. Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.
Peters M; Kanthabalan A; Shah TT; McCartan N; Moore CM; Arya M; van der Voort van Zyp JR; Moerland MA; Hindley RG; Emberton M; Ahmed HU
Urol Oncol; 2018 Jan; 36(1):13.e1-13.e10. PubMed ID: 28927782
[TBL] [Abstract][Full Text] [Related]
4. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
[TBL] [Abstract][Full Text] [Related]
5. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients.
Crouzet S; Blana A; Murat FJ; Pasticier G; Brown SCW; Conti GN; Ganzer R; Chapet O; Gelet A; Chaussy CG; Robertson CN; Thuroff S; Ward JF
BJU Int; 2017 Jun; 119(6):896-904. PubMed ID: 28063191
[TBL] [Abstract][Full Text] [Related]
6. Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
Rakauskas A; Shah TT; Peters M; Randeva JS; Hosking-Jervis F; Schmainda MJ; Orczyck C; Emberton M; Arya M; Moore C; Ahmed HU
Urol Oncol; 2021 Dec; 39(12):830.e1-830.e8. PubMed ID: 34049783
[TBL] [Abstract][Full Text] [Related]
7. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
8. Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy.
Uddin Ahmed H; Cathcart P; Chalasani V; Williams A; McCartan N; Freeman A; Kirkham A; Allen C; Chin J; Emberton M
Cancer; 2012 Jun; 118(12):3071-8. PubMed ID: 22071795
[TBL] [Abstract][Full Text] [Related]
9. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
10. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
Reddy D; Peters M; Shah TT; van Son M; Tanaka MB; Huber PM; Lomas D; Rakauskas A; Miah S; Eldred-Evans D; Guillaumier S; Hosking-Jervis F; Engle R; Dudderidge T; Hindley RG; Emara A; Nigam R; McCartan N; Valerio M; Afzal N; Lewi H; Orczyk C; Ogden C; Shergill I; Persad R; Virdi J; Moore CM; Arya M; Winkler M; Emberton M; Ahmed HU
Eur Urol; 2022 Apr; 81(4):407-413. PubMed ID: 35123819
[TBL] [Abstract][Full Text] [Related]
11. Salvage high-intensity focused ultrasound (S-HIFU) for recurrence after primary radiotherapy of prostate cancer.
Long Depaquit T; Campagna J; Bastide C; Baboudjian M; Corral R; Uleri A; Toledano H
Fr J Urol; 2024 Jun; 34(5):102633. PubMed ID: 38547931
[TBL] [Abstract][Full Text] [Related]
12. Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study.
Ahmed HU; Cathcart P; McCartan N; Kirkham A; Allen C; Freeman A; Emberton M
Cancer; 2012 Sep; 118(17):4148-55. PubMed ID: 22907704
[TBL] [Abstract][Full Text] [Related]
13. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
[TBL] [Abstract][Full Text] [Related]
14. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
15. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
16. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
[TBL] [Abstract][Full Text] [Related]
17. Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.
Dickinson L; Arya M; Afzal N; Cathcart P; Charman SC; Cornaby A; Hindley RG; Lewi H; McCartan N; Moore CM; Nathan S; Ogden C; Persad R; van der Meulen J; Weir S; Emberton M; Ahmed HU
Eur Urol; 2016 Oct; 70(4):668-674. PubMed ID: 26951947
[TBL] [Abstract][Full Text] [Related]
18. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU
Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750
[TBL] [Abstract][Full Text] [Related]
19. Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.
Ganzer R; Fritsche HM; Brandtner A; Bründl J; Koch D; Wieland WF; Blana A
BJU Int; 2013 Aug; 112(3):322-9. PubMed ID: 23356910
[TBL] [Abstract][Full Text] [Related]
20. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
